Germ Cell Tumors of the Ovary: A Review.
Ramalingam P.
Semin Diagn Pathol. 2023 Jan;40(1):22-36. doi: 10.1053/j.semdp.2022.07.004. Epub 2022 Jul 29.
The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.
Kurman RJ, Shih IeM.
Am J Surg Pathol. 2010 Mar;34(3):433-43. doi: 10.1097/PAS.0b013e3181cf3d79.
Tumor metabolism rewiring in epithelial ovarian cancer.
Wang M, Zhang J, Wu Y.
J Ovarian Res. 2023 Jun 5;16(1):108. doi: 10.1186/s13048-023-01196-0.
Single-Cell Sequencing of Malignant Ascites Reveals Transcriptomic Remodeling of the Tumor Microenvironment during the Progression of Epithelial Ovarian Cancer.
Li Y, Wang W, Wang D, Zhang L, Wang X, He J, Cao L, Li K, Xie H.
Genes (Basel). 2022 Dec 2;13(12):2276. doi: 10.3390/genes13122276.
Preoperative Differentiation of Benign and Malignant Non-epithelial Ovarian Tumors: Clinical Features and Tumor Markers.
Gomes TA, Campos EA, Yoshida A, Sarian LO, Andrade LALA, Derchain SF.
Rev Bras Ginecol Obstet. 2020 Sep;42(9):555-561. doi: 10.1055/s-0040-1712993. Epub 2020 Sep 29.
Identification of epithelial ovarian tumor-specific aptamers.
Benedetto G, Hamp TJ, Wesselman PJ, Richardson C.
Nucleic Acid Ther. 2015 Jun;25(3):162-72. doi: 10.1089/nat.2014.0522. Epub 2015 Apr 20.
Primary ovarian neuroendocrine neoplasia with concurrent large epithelial borderline ovarian tumor, coexistent with non-malignant pleural effusion and multiple uterine fibroids: a case report and review of the literature.
Mohsin M, Dube R, Hamza D, Ali M, Garg H.
J Med Case Rep. 2025 Mar 19;19(1):125. doi: 10.1186/s13256-025-05170-w.
Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcome.
Auer K, Bachmayr-Heyda A, Aust S, Sukhbaatar N, Reiner AT, Grimm C, Horvat R, Zeillinger R, Pils D.
Oncotarget. 2015 Jul 10;6(19):17261-75. doi: 10.18632/oncotarget.3746.
Malignant rhabdoid tumor arising in a mixed epithelial, stromal tumor of kidney: report of a male case, review of the literature.
Gokden N, Dawson K, Lindberg M.
Pathol Res Pract. 2020 Oct;216(10):153151. doi: 10.1016/j.prp.2020.153151. Epub 2020 Jul 31.
Characterizing Endocrine Status, Tumor Hypoxia and Immunogenicity for Therapy Success in Epithelial Ovarian Cancer.
Pereira M, Matuszewska K, Jamieson C, Petrik J.
Front Endocrinol (Lausanne). 2021 Nov 17;12:772349. doi: 10.3389/fendo.2021.772349. eCollection 2021.
